Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair

Area of Science:

• Regenerative Medicine
• Wound Healing Biology
• Stem Cell Therapy

Background:

• Cutaneous wounds, especially chronic and deep dermal types, represent a significant healthcare challenge due to limited effective therapies.
• Understanding cellular and molecular responses to injury has not yet translated into reliable treatments for impaired wound healing.
• Hypertrophic scarring is a common complication of deep dermal wounds, further complicating patient outcomes.

Purpose of the Study:

• To review the evidence supporting the therapeutic potential of multipotent mesenchymal stem/stromal cells (MSCs) for treating impaired wound healing.
• To discuss the mechanisms by which MSCs may promote cutaneous repair, including differentiation and paracrine signaling.
• To highlight the challenges that need to be addressed for the clinical application of MSCs in wound care.

Main Methods:

• Literature review of studies investigating MSCs in the context of wound healing.
• Analysis of preclinical and clinical data on MSC treatment for acute, chronic, and deep dermal wounds.
• Examination of the proposed mechanisms of action for MSCs in tissue regeneration.

Main Results:

• MSC treatment accelerates wound closure in both acute and chronic wound models.
• Therapeutic effects include enhanced epithelialization, granulation tissue formation, and angiogenesis.
• While some MSC differentiation in wounds is observed, paracrine signaling via soluble factors is considered the primary mechanism of action.

Conclusions:

• MSCs demonstrate significant therapeutic potential for accelerating the healing of various cutaneous wounds.
• The primary therapeutic benefit appears to stem from MSC-secreted factors that modulate the local wound environment.
• Further research and overcoming current challenges are necessary for the effective clinical use of MSCs in treating slow-healing wounds.